Quince Therapeutics (QNCX) Long-Term Investments (2019 - 2023)

Quince Therapeutics' Long-Term Investments history runs 5 years deep, the most recent figure standing at $500000.0 for Q1 2023.

• In Q1 2023, Long-Term Investments fell 97.4% year-over-year to $500000.0; the TTM figure through Mar 2023 stood at $500000.0 (down 97.4% YoY), while the FY2022 annual figure was $3.6 million, down 82.05% from the prior year.
• Long-Term Investments for Q1 2023 stood at $500000.0, down from $3.6 million in the prior quarter.
• The five-year high for Long-Term Investments was $66.1 million in Q2 2020, with the low at $500000.0 in Q1 2023.
• The 5-year median for Long-Term Investments is $19.2 million (2022), against an average of $24.0 million.
• The sharpest annual moves came in 2020 and 2023: Long-Term Investments surged 1028.86% in 2020, then tumbled 97.4% in 2023.
• Quince Therapeutics' Long-Term Investments stood at $16.8 million in 2019, then soared by 201.04% to $50.5 million in 2020, then sank by 60.5% to $19.9 million in 2021, then slumped by 82.05% to $3.6 million in 2022, then sank by 86.03% to $500000.0 in 2023.
• Business Quant data shows QNCX's Long-Term Investments at $500000.0 in Q1 2023, $3.6 million in Q4 2022, and $5.0 million in Q3 2022.